Federation des caisses Desjardins du Quebec’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.2K Buy
3,684
+563
+18% +$2.82K ﹤0.01% 2137
2026
Q1
$14.9K Hold
3,121
– – ﹤0.01% 2186
2025
Q4
$25.3K Hold
3,121
– – ﹤0.01% 1997
2025
Q3
$18.4K Buy
3,121
+667
+27% +$4.73K ﹤0.01% 2067
2025
Q2
$20.4K Hold
2,454
– – ﹤0.01% 1806
2025
Q1
$15.4K Buy
2,454
+2,423
+7,816% +$21K ﹤0.01% 1815
2024
Q4
$273 Hold
31
– – ﹤0.01% 2438
2024
Q3
$274 Sell
31
-1
-3% -$10 ﹤0.01% 2443
2024
Q2
$317 Hold
32
– – ﹤0.01% 2294
2024
Q1
$650 Hold
32
– – ﹤0.01% 2218
2023
Q4
$474 Buy
+32
New +$596 ﹤0.01% 2203

Other funds holding HELP

Federation des caisses Desjardins du Quebec's HELP Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Helus Pharma Inc. Common Stock (HELP) stake by 18% in Q2 2026, buying an estimated $2.82K and bringing the position to 3,684 shares worth $24.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2137.

Federation des caisses Desjardins du Quebec first reported a position in HELP in Q4 2023 and has held it in 11 quarters since. The position peaked at $25.3K in Q4 2025. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 3,684 shares of Helus Pharma Inc. Common Stock worth $24.2K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 563 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $2.82K.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2137 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Helus Pharma Inc. Common Stock in Q4 2023 and has held it in 11 quarters since.
  • Federation des caisses Desjardins du Quebec's Helus Pharma Inc. Common Stock position peaked at $25.3K in Q4 2025.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.